» Articles » PMID: 38339890

Topographic Metabolism-function Relationships in Alzheimer's Disease: A Simultaneous PET/MRI Study

Overview
Journal Hum Brain Mapp
Publisher Wiley
Specialty Neurology
Date 2024 Feb 10
PMID 38339890
Authors
Affiliations
Soon will be listed here.
Abstract

Disruptions of neural metabolism and function occur in parallel during Alzheimer's disease (AD). While many studies have shown diverse metabolic-functional relationships in specific brain regions, much less is known about how large-scale network-level functional activity is associated with the topology of metabolism in AD. In this study, we took the advantages of simultaneous PET/MRI and multivariate analyses to investigate the associations between AD-related stereotypical spatial patterns (topographies) of glucose metabolism, measured by fluorodeoxyglucose PET, and functional connectivity, measured by resting-state functional MRI. A total of 101 participants, including 37 patients with AD, 25 patients with mild cognitive impairment (MCI), and 39 cognitively normal controls, underwent PET/MRI scans and cognitive assessments. Three pairs of distinct but optimally correlated metabolic and functional topographies were identified, encompassing large-scale networks including the default-mode, executive and control, salience, attention, and subcortical networks. Importantly, the metabolic-functional associations were not only limited to one-to-one-corresponding regions, but also occur in remote and non-overlapping regions. Furthermore, both glucose metabolism and functional connectivity, as well as their linkages, exhibited various degrees of disruptions in patients with MCI and AD, and were correlated with cognitive decline. In conclusion, our results support distributed and heterogeneous topographic associations between metabolism and function, which are jeopardized by AD. Findings of this study may deepen our understanding of the pathological mechanism of AD through the perspectives of both local energy efficiency and long-term interactions between synaptic disruption and functional disconnection contributing to the clinical symptomatology in AD.

Citing Articles

Treatment of Acute and Long-COVID, Diabetes, Myocardial Infarction, and Alzheimer's Disease: The Potential Role of a Novel Nano-Compound-The Transdermal Glutathione-Cyclodextrin Complex.

Yutani R, Venketaraman V, Sheren N Antioxidants (Basel). 2024; 13(9).

PMID: 39334765 PMC: 11429141. DOI: 10.3390/antiox13091106.


Topographic metabolism-function relationships in Alzheimer's disease: A simultaneous PET/MRI study.

Li W, Zhang M, Huang R, Hu J, Wang L, Ye G Hum Brain Mapp. 2024; 45(2):e26604.

PMID: 38339890 PMC: 10964919. DOI: 10.1002/hbm.26604.

References
1.
Yao H, Liu Y, Zhou B, Zhang Z, An N, Wang P . Decreased functional connectivity of the amygdala in Alzheimer's disease revealed by resting-state fMRI. Eur J Radiol. 2013; 82(9):1531-8. DOI: 10.1016/j.ejrad.2013.03.019. View

2.
Palmqvist S, Scholl M, Strandberg O, Mattsson N, Stomrud E, Zetterberg H . Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity. Nat Commun. 2017; 8(1):1214. PMC: 5663717. DOI: 10.1038/s41467-017-01150-x. View

3.
Ding C, Du W, Zhang Q, Wang L, Han Y, Jiang J . Coupling relationship between glucose and oxygen metabolisms to differentiate preclinical Alzheimer's disease and normal individuals. Hum Brain Mapp. 2021; 42(15):5051-5062. PMC: 8449101. DOI: 10.1002/hbm.25599. View

4.
Mosconi L, Pupi A, de Leon M . Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease. Ann N Y Acad Sci. 2008; 1147:180-95. PMC: 2661241. DOI: 10.1196/annals.1427.007. View

5.
Cox R . AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res. 1996; 29(3):162-73. DOI: 10.1006/cbmr.1996.0014. View